日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Testing the usability and acceptability of the NON-STOP app for children with Perthes' disease

测试 NON-STOP 应用程序对患有佩尔特斯病的儿童的可用性和接受度

Galloway, Adam M; Keene, David J; Cleary, Kerry; Gabriele, Ella; Holton, Colin; Pini, Simon; Redmond, Anthony C; Siddle, Heidi J; Richards, Suzanne; Perry, Daniel C

From theory to practice: insights into intervention development of the NON-STOP app for children with Perthes' disease

从理论到实践:深入了解针对佩尔特斯病患儿的 NON-STOP 应用程序的干预开发

Galloway, Adam M; Anderson, Anna M; Casimir, Emma; Holton, Colin; Keene, David J; Redmond, Anthony C; Siddle, Heidi J; Richards, Suzanne; Perry, Daniel C

Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity

曼彻斯特间歇性和日常饮食1型糖尿病应用程序研究(MIDDAS-Type 1):一项针对1型糖尿病合并超重和肥胖患者的间歇性和持续性低能量饮食随机可行性试验方案

McDiarmid, Sarah; Harvie, Michelle; Aglan, Azza; Winterbottom, Hannah; Mubita, Womba; Hulme, Amanda; Davies, Jane; Yates, James; Krizak, Suzanne; Perry, Diane; Issa, Basil G

Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide

β-防御素样蛋白 Helianthamide 对人类 α-淀粉酶有强效抑制作用

Christina Tysoe, Leslie K Williams, Robert Keyzers, Nham T Nguyen, Chris Tarling, Jacqueline Wicki, Ethan D Goddard-Borger, Adeleke H Aguda, Suzanne Perry, Leonard J Foster, Raymond J Andersen, Gary D Brayer, Stephen G Withers

Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation

小胶质细胞和尿激酶型纤溶酶原激活物受体/uPA系统在先天性脑炎症中的作用

Cunningham, Orla; Campion, Suzanne; Perry, V Hugh; Murray, Carol; Sidenius, Nicolai; Docagne, Fabian; Cunningham, Colm